Our CEO Yogev Debbi is speaking next week at the 14th annual #PODD - Partnership Opportunities In Drug Delivery Conference in Boston. Stop by to see our company presentation on Tuesday, October 29th during the Soapbox Presentations from 11:55-12:40 pm ET.
About us
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
Employees at Mana.bio
Updates
-
Our dear Scientific Co-founder Kira Radinsky was interviewed to Crafted. and shared her opinion on AI, how we use it at Mana and the future potential of AI in life science. Excited to have such amazing team members with us, on our mission to unlock RNA delivery with our programmable AI platform. Links to listen below
Host of CRAFTED., a 2x Webby-honored tech podcast | Product & Growth Leader | Founder of Modern Product Minds
Which industries do you think will be disrupted most by AI? For Kira Radinsky, the answer is obvious... It's chemistry and biology. And on the latest CRAFTED., a true pioneer tells us why... Kira is the CEO of Diagnostic Robotics, which uses #AI to make predictions that help patients get better healthcare. She’s also the co-founder of Mana.bio, which uses AI to accelerate drug discovery, and has done things in three months that used to take 20 years! On this episode, Kira shares her love for making predictions. It's something she became famous for a decade ago when she build systems that successfully predicted cholera outbreaks and riots. Plus, why she wants "AI to replace me as a scientist.” Enjoy the latest CRAFTED., all about AI and the future of medicine! 🎧 Spotify: https://lnkd.in/e4KGYkzE 🎧 Apple: https://lnkd.in/etfBk_3F 📺 YouTube: https://lnkd.in/ev7_kU2T *** CRAFTED. is a Webby-honored podcast about great products and the people who make them. This season in partnership with Docker, Inc.
-
News Update: Our team has signed a collaborative research agreement with Sheba Medical Center, Tel Hashomer. Through this study we plan to utilize our programmable AI platform to enhance personalized medicine by using RNA delivery to reprogram T-cells in the fight against challenging diseases such as cancer and autoimmune disorders. We are excited to be working with Sheba Medical Center on such a novel study to push the boundaries of RNA delivery. Our AI based programmable platform enables the discovery of efficient, safe, more precise delivery formulations - providing us the opportunity to unlock the full potential of RNA therapies across a wide range of disease areas. https://lnkd.in/dHueK-yU #RNA #LNP #AI
-
We’ve been recognized by TheMarker as one of the Top 20 promising start-ups in Israel alongside PhaseV, Protai, caVos Biotherapeutics, and more. This is a testament to the resilience of our community - so many exciting ideas becoming a reality. You can read the full piece here: https://lnkd.in/dmQpZQQH
-
-
We're proud to announce that Mana has been accepted into the #NVIDIAInception program. We are honored to be part of a group of startups driving changes in #AI across industries and around the world. This program will provide us with several opportunities, including access to NVIDIA's latest technological resources and the chance to connect with peers who are working through similar challenges. This is yet another exciting milestone for us as we continue to grow and work to find improved RNA delivery options.
-
-
Proud of our Scientific co-founder Prof. Avi Schroeder for being appointed to be the President of the Controlled Release Society! We wish Avi and the community much impact and success ahead.
Professor of Chemical Engineering at Technion - Israel Institute of Technology, President - Controlled Release Society
Honored to be appointed President of the Controlled Release Society this Friday. Excited to serve our community of scientists, engineers, clinicians, and innovators. Together, we'll lead cutting-edge science and foster strong collaborations to translate innovative medicines faster, benefiting patients worldwide. Controlled Release Society (CRS)
-
-
Our CEO Yogev Debbi recently published his thoughts on the importance of speaking the language of AI in Pharma and why the future of human health depends on it. Dig into why the industry needs to do more engineering and less gambling when it comes to drug development and how to best re-frame the way lab work is measured in order to best embrace AI. See the full piece below #pharma #AI #lab #data
Excited to share my thoughts on the importance of speaking the language of AI in Pharma and why the future of human health depends on it. The industry needs to do more engineering and less gambling when it comes to drug development. It is of vital importance that pharma and biotech leaders begin to shift the mindset of their organizations to generate data in a way that will allow the AI revolution to disrupt and truly make an impact on the industry and future patients. See the full piece here: https://lnkd.in/d_2bM-Cr #ai #pharma #data #science #techbio
The Future of Human Health Depends on the Ability of Pharma to Speak the Language of AI
medium.com
-
We are excited to sponsor a Workshop at the Controlled Release Society conference this morning on The Application of AI to Drug Delivery. Co-sponsored with METiS Therapeutics and organized by Daniel Heller and Avi Schroeder, in the beautiful Bologna, Italy. Come and listen to so many terrific experts in this area. #AI #drugdelivery #LNP #data
-
-
Mana.bio reposted this
💊 𝗡𝗮𝗻𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆-𝗯𝗮𝘀𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀: 𝟱 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵! 👀 🔵 The growing use of nanotechnology in drug delivery is transforming healthcare by allowing for targeted, efficient, and controlled release of medications! 🔵 These young companies are great examples of startups leading the way in this transformation, developing state-of-the-art technologies that improve the precision and effectiveness of treatments! 🔵 From targeted cancer treatments to advanced gene therapies, these startups are laying the groundwork for a new era in medicine! 🔵 Take a look through the startups in our list: 💠 Aera Therapeutics 💠 Orion Therapeutics, Inc. 💠 NanoPhoria 💠 NanoVation Therapeutics™ 💠 Mana.bio ---------------------------------------------- What startups can you add to the list? Source: VentureRadar #startup #drugdelivery #lipidnanoparticle #LNP #liposome #biotechnology #biopharmaindustry #nanotechnology
-
-
Mana.bio reposted this
I was honored to present as a part of Biomed Israel 2024 last week discussing how to "Unlock Extra-Hepatic Delivery Using Machine Learning." Our work at Mana.bio, along with many other companies showed the potential for how #AI will continue to impact different aspects of #pharma including drug development, target discovery, diagnostics and more. Overall the event showed just how many advancements have been made in genetic medicine therapeutics, delivery and clinical progress and it was heartening to see increased innovative science moving from academic research into newly functioning startups. We were thrilled to observe the potential in delivery of genetic medicine that will begin to disrupt so many therapeutic areas and we are excited to push forward as a community to leverage AI to unlock that promise.
-